111 related articles for article (PubMed ID: 1349525)
21. Characterisation of yeast phosphoglycerate kinase modified by mutagenesis at residue 21.
Walker PA; Joâo HC; Littlechild JA; Williams RJ; Watson HC
Eur J Biochem; 1992 Jul; 207(1):29-37. PubMed ID: 1628654
[TBL] [Abstract][Full Text] [Related]
22. Yeast phosphoglycerate kinase: investigation of catalytic function by site-directed mutagenesis.
Wilson CA; Hardman N; Fothergill-Gilmore LA; Gamblin SJ; Watson HC
Biochem J; 1987 Jan; 241(2):609-14. PubMed ID: 3297036
[TBL] [Abstract][Full Text] [Related]
23. The steady-state kinetics of yeast phosphoglycerate kinase. Anomalous kinetic plots and the effects of salts on activity.
Scopes RK
Eur J Biochem; 1978 Apr; 85(2):503-16. PubMed ID: 348474
[TBL] [Abstract][Full Text] [Related]
24. A proton-NMR study of a site-directed mutation (His388----Glu) in the interdomain region of yeast phosphoglycerate kinase. Implications for domain movement.
Graham HC; Williams RJ; Littlechild JA; Watson HC
Eur J Biochem; 1991 Mar; 196(2):261-9. PubMed ID: 2007400
[TBL] [Abstract][Full Text] [Related]
25. Site-directed mutations of arginine 65 at the periphery of the active site cleft of yeast 3-phosphoglycerate kinase enhance the catalytic activity and eliminate anion-dependent activation.
Sherman MA; Dean SA; Mathiowetz AM; Mas MT
Protein Eng; 1991 Dec; 4(8):935-40. PubMed ID: 1817256
[TBL] [Abstract][Full Text] [Related]
26. Site-directed mutagenesis of yeast phosphoglycerate kinase. The 'basic-patch' residue arginine 168.
Walker PA; Littlechild JA; Hall L; Watson HC
Eur J Biochem; 1989 Jul; 183(1):49-55. PubMed ID: 2502400
[TBL] [Abstract][Full Text] [Related]
27. Effect of anthraquinone dyes and evaluation of the kinetic mechanism of yeast phosphoglycerate kinase.
Beissner RS; Rudolph FB
J Biol Chem; 1979 Jul; 254(14):6273-7. PubMed ID: 376530
[TBL] [Abstract][Full Text] [Related]
28. NMR analysis of the interdomain region of yeast phosphoglycerate kinase.
Wilson HR; Williams RJ; Littlechild JA; Watson HC
Eur J Biochem; 1988 Jan; 170(3):529-38. PubMed ID: 3276512
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of yeast phosphoglycerate kinase by lanthanide-ATP complexes.
Tanswell P; Westhead EW; Williams RJ
FEBS Lett; 1974 Nov; 48(1):60-3. PubMed ID: 4609802
[No Abstract] [Full Text] [Related]
30. Nuclear magnetic resonance studies of isolated structural domains of yeast phosphoglycerate kinase.
Fairbrother WJ; Minard P; Hall L; Betton JM; Missiakas D; Yon JM; Williams RJ
Protein Eng; 1989 Oct; 3(1):5-11. PubMed ID: 2682611
[TBL] [Abstract][Full Text] [Related]
31. Product inhibition studies of yeast phosphoglycerate kinase evaluating properties of multiple substrate binding sites.
Schierbeck B; Larsson-Raźnikiewicz M
Biochim Biophys Acta; 1979 May; 568(1):195-204. PubMed ID: 375985
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance studies on manganese-nucleotide complexes of phosphoglycerate kinase.
Chapman BE; O'Sullivan WJ; Scopes RK; Reed GH
Biochemistry; 1977 Mar; 16(5):1005-10. PubMed ID: 321006
[TBL] [Abstract][Full Text] [Related]
33. The effects of anions, substrates, metal ions and sulfhydryl reagents on the proteolytic susceptibility of yeast phosphoglycerate kinase.
Wrobel JA; Stinson RA
Biochim Biophys Acta; 1981 Dec; 662(2):236-45. PubMed ID: 7032600
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of phosphoglycerate kinase by salicylates.
Larsson-Raźnikiewicz M; Wiksell E
Biochim Biophys Acta; 1978 Mar; 523(1):94-100. PubMed ID: 343818
[TBL] [Abstract][Full Text] [Related]
35. Studies with inhibitors of the glycolytic enzyme phosphoglycerate kinase for potential treatment of cardiovascular and respiratory disorders.
Mcharg J; Littlechild JA
J Pharm Pharmacol; 1996 Feb; 48(2):201-5. PubMed ID: 8935172
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the kinetics of reversible enzyme inhibition by a general algebraic method. Application to multisite inhibition of the phosphoglycerate kinase from Trypanosoma brucei.
Puech J; Callens M; Willson M
J Enzyme Inhib; 1998; 14(1):27-47. PubMed ID: 10520758
[TBL] [Abstract][Full Text] [Related]
37. Site-directed mutagenesis of yeast phosphoglycerate kinase. Arginines 65, 121 and 168.
Barber MD; Gamblin SJ; Watson HC; Littlechild JA
FEBS Lett; 1993 Apr; 320(3):193-7. PubMed ID: 8462685
[TBL] [Abstract][Full Text] [Related]
38. 31P NMR study of bound reactants and products of yeast 3-phosphoglycerate kinase at equilibrium and the effect of sulfate ion.
Rao BD; Cohn M; Scopes RK
J Biol Chem; 1978 Nov; 253(22):8056-60. PubMed ID: 361736
[No Abstract] [Full Text] [Related]
39. Photochemically induced dynamic nuclear polarization NMR study of yeast and horse muscle phosphoglycerate kinase.
Scheffler JE; Cohn M
Biochemistry; 1986 Jul; 25(13):3788-96. PubMed ID: 3527256
[TBL] [Abstract][Full Text] [Related]
40. Substrate-assisted movement of the catalytic Lys 215 during domain closure: site-directed mutagenesis studies of human 3-phosphoglycerate kinase.
Flachner B; Varga A; Szabó J; Barna L; Hajdú I; Gyimesi G; Závodszky P; Vas M
Biochemistry; 2005 Dec; 44(51):16853-65. PubMed ID: 16363799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
